Scholars@Duke

Bevacizumab for retinopathy of prematurity.

Publication ,  Journal Article
Lim, LS; Mitchell, P; Wong, TY
Published in: N Engl J Med
June 16, 2011
Published version (DOI) Link to item

Duke Scholars

Tien Yin Wong
Author Tien Yin Wong Ophthalmology
Altmetric Attention Stats
Dimensions Citation Stats

Published In

N Engl J Med

DOI

10.1056/NEJMc1103460

EISSN

1533-4406

Publication Date

June 16, 2011

Volume

364

Issue

24

Start / End Page

2360

Location

United States

Related Subject Headings

  • Vascular Endothelial Growth Factor A
  • Retinopathy of Prematurity
  • Research Design
  • Laser Therapy
  • Intravitreal Injections
  • Infant, Premature
  • Infant, Newborn
  • Humans
  • General & Internal Medicine
  • Body Weight
 

Citation

APA
Chicago
ICMJE
MLA
NLM
Lim, L. S., Mitchell, P., & Wong, T. Y. (2011). Bevacizumab for retinopathy of prematurity. N Engl J Med, 364(24), 2360. https://doi.org/10.1056/NEJMc1103460
Lim, Laurence S., Paul Mitchell, and Tien Y. Wong. “Bevacizumab for retinopathy of prematurity.” N Engl J Med 364, no. 24 (June 16, 2011): 2360. https://doi.org/10.1056/NEJMc1103460.
Lim LS, Mitchell P, Wong TY. Bevacizumab for retinopathy of prematurity. N Engl J Med. 2011 Jun 16;364(24):2360.
Lim, Laurence S., et al. “Bevacizumab for retinopathy of prematurity.” N Engl J Med, vol. 364, no. 24, June 2011, p. 2360. Pubmed, doi:10.1056/NEJMc1103460.
Lim LS, Mitchell P, Wong TY. Bevacizumab for retinopathy of prematurity. N Engl J Med. 2011 Jun 16;364(24):2360.

Published In

N Engl J Med

DOI

10.1056/NEJMc1103460

EISSN

1533-4406

Publication Date

June 16, 2011

Volume

364

Issue

24

Start / End Page

2360

Location

United States

Related Subject Headings

  • Vascular Endothelial Growth Factor A
  • Retinopathy of Prematurity
  • Research Design
  • Laser Therapy
  • Intravitreal Injections
  • Infant, Premature
  • Infant, Newborn
  • Humans
  • General & Internal Medicine
  • Body Weight